Then genomic alteration analysis of PDIA3 indicated that the alterations of PDIA3 across pan-cancer were not universal, and the most frequently altered cancer type was lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), exceeding 6% DLBC patients and was mostly deep deletion (Figure 1D). This evidence concerns the gene PDIA3 and cancer.